CLPT

CLPT R&D to Revenue

37.59%Fiscal year

Period ending:

CLPT FY R&D/Revenue%
CLPT FY R&D/Revenue235.35%2.52%
2010-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

CLPT r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 16 observations from Dec 31, 2010 to Dec 31, 2025.

Clearpoint Neuro Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
37.5889%
39.4775%
48.8791%
53.0096%
56.9421%
36.5266%
25.0513%
31.4165%
38.1289%
45.7118%
42.6045%
91.4726%
74.3635%
31.6705%
111.3486%
212.8165%

Compare r&d to revenue

All CLPT financial metrics · CLPT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.